Inflammatory Demyelinating Polyneuropathy
📧 Sign up to get email alerts when something new happens for Inflammatory Demyelinating Polyneuropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-01-01Clinical Trial Update: Universal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System. [EARLY_Phase 1]
A Phase 1 trial evaluating universal CAR-T cells for refractory autoimmune diseases of the nervous system; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2024-12-05Clinical Trial Update: Immunoadsorption Versus Immunoglobulins for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) [Phase 2]
A Phase 2 study comparing immunoadsorption with intravenous immunoglobulin for chronic inflammatory demyelinating polyrneuropathy (CIDP) is …
-
CLINICAL_TRIALS research · 2024-12-04Clinical Trial Update: Rituximab Induced Remission in Patients With Chronic Inflammatory Demyelinating Polyneuropathy [Phase 3]
Phase 3 clinical trial evaluating rituximab for inducing remission in chronic inflammatory demyelinating polyneuropathy is currently recruit…
-
CLINICAL_TRIALS trial_result · 2024-11-25Clinical Trial Update: To Assess Efficacy and Safety of Batoclimab in Adult Participants With Active CIDP [Phase 2]
A Phase 2 clinical trial update evaluating the efficacy and safety of batoclimab in adults with active Chronic Inflammatory Demyelinating Po…
-
CLINICAL_TRIALS research · 2024-10-30Clinical Trial Update: Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System [EARLY_Phase 1]
An early-phase clinical trial is investigating CT103A cell therapy for relapsed/refractory antibody-associated inflammatory diseases of the …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: Subcutaneous Immunoglobulin for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) [NA]
The University of South Florida completed a clinical trial evaluating subcutaneous immunoglobulin for chronic inflammatory demyelinating pol…
-
CLINICAL_TRIALS trial_result · 2024-08-20Clinical Trial Update: A Study to Assess the Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves) [Phase 2]
A Phase 2 study evaluating the safety and efficacy of a subcutaneous formulation of efgartigimod in adults with Chronic Inflammatory Demyeli…
-
CLINICAL_TRIALS trial_result · 2024-07-17Clinical Trial Update: Electronic Monitoring of Disease Activity in Patients With Chronic Inflammatory Demyelinating Polyneuropathy
A completed clinical trial evaluating electronic monitoring of disease activity in patients with chronic inflammatory demyelinating polyneur…
-
CLINICAL_TRIALS trial_result · 2024-07-05Clinical Trial Update: A First in HumanTrial to Evaluate The Safety, Tolerability, And Pharmacokinetics Of PF-06755347 [Phase 1]
This first-in-human Phase 1 trial of PF-06755347 evaluating safety, tolerability, and pharmacokinetics was terminated, and results have been…
-
CLINICAL_TRIALS research · 2024-05-17Clinical Trial Update: Subcutaneous Immunoglobulin in De-novo CIDP (SIDEC) [Phase 4]
A Phase 4 clinical trial (SIDEC) is evaluating subcutaneous immunoglobulin for de novo Chronic Inflammatory Demyelinating Polyneuropathy. Th…
-
CLINICAL_TRIALS trial_result · 2024-03-26Clinical Trial Update: Rituximab in Chronic Inflammatory Demyelinating Polyradiculoneuropathy [Phase 3]
Phase 3 trial of Rituximab in chronic inflammatory demyelinating polyradiculoneuropathy has completed.
-
CLINICAL_TRIALS trial_result · 2023-07-14Clinical Trial Update: Non-invasive Vagus Nerve Stimulation (nVNS) in Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) [NA]
A pediatric trial evaluating non-invasive vagus nerve stimulation (nVNS) for chronic inflammatory demyelinating polyneuropathy (CIDP) has be…
-
CLINICAL_TRIALS trial_result · 2023-05-26Clinical Trial Update: A Proof of Concept Study With Rituximab in Patients With CIDP Not Responding to Conventional Immune Therapy [Phase 2]
A Phase 2 proof-of-concept trial evaluating rituximab in CIDP patients who did not respond to conventional immune therapy. Overall status is…
-
CLINICAL_TRIALS trial_result · 2021-02-16Clinical Trial Update: Study to Evaluate Safety and Efficacy of Three Different Dosages of NewGam in Patients With Chronic Inflammatory Demyelinating Poly (Radiculo) Neuropathy [Phase 3]
Phase 3 trial evaluating three different dosages of NewGam for chronic inflammatory demyelinating polyneuropathy has completed with results …
-
CLINICAL_TRIALS trial_result · 2020-11-02Clinical Trial Update: SERENDEM : MD1003 in Patients Suffering From Demyelinating Neuropathies, an Open Label Pilot Study [Phase 2]
Phase 2 open-label pilot study of MD1003 (serendem) in demyelinating neuropathies completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-08-19Clinical Trial Update: Lipoic Acid to Treat Chronic Inflammatory Demyelinating Polyneuropathy [Phase 2]
Phase 2 trial evaluating lipoic acid for chronic inflammatory demyelinating polyneuropathy (CIDP) has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-07-23Clinical Trial Update: Hematopoietic Stem Cell Transplantation in Chronic Inflammatory Demyelinating Polyneuropathy [Phase 2]
Phase 2 clinical trial update on hematopoietic stem cell transplantation for chronic inflammatory demyelinating polyneuropathy has completed…
-
CLINICAL_TRIALS trial_result · 2018-10-02Clinical Trial Update: Extension Study of Maintenance Treatment With Subcutaneous Immunoglobulin (IgPro20) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) [Phase 3]
Phase 3 extension study evaluating maintenance subcutaneous immunoglobulin (IgPro20) in CIDP has been completed with posted results.
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Treatment With Subcutaneous Immunoglobulin (IgPro20) [Phase 3]
A Phase 3 study evaluating subcutaneous immunoglobulin IgPro20 for chronic inflammatory demyelinating polyneuropathy has completed and poste…
-
CLINICAL_TRIALS trial_result · 2018-03-09Clinical Trial Update: Diffusion Tensor Imaging in Chronic Inflammatory Demyelinating Polyneuropathy (PIDC)
The study evaluating diffusion tensor imaging in chronic inflammatory demyelinating polyneuropathy and Charcot-Marie-Tooth disease has compl…
-
CLINICAL_TRIALS research · 2017-05-25Clinical Trial Update: Panzyga in CIDP Administered at Different Infusion Rates [Phase 3]
A Phase 3 clinical trial update evaluating Panzyga for chronic inflammatory demyelinating polyneuropathy at different infusion rates.
-
CLINICAL_TRIALS withdrawal · 2017-05-18Clinical Trial Update: Alemtuzumab in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIPD) [Phase 4]
Phase 4 trial evaluating alemtuzumab for Chronic Inflammatory Demyelinating Polyneuropathy has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-02-03Clinical Trial Update: Magnetic Resonance Diagnostics of Diabetic Peripheral Neuropathy
This clinical trial evaluates magnetic resonance techniques for diagnosing diabetic peripheral neuropathy and related hereditary and inflamm…
-
CLINICAL_TRIALS research · 2016-11-11Clinical Trial Update: IVIg for Demyelination in Diabetes Mellitus [Phase 4]
A Phase 4 clinical trial update evaluating intravenous immunoglobulin (IVIg) for demyelinating peripheral neuropathies in diabetes mellitus,…
-
CLINICAL_TRIALS withdrawal · 2016-07-18Clinical Trial Update: Pilot Study of Acthar® Gel in Chronic Inflammatory Demyelinating Neuropathy [Phase 2]
A Phase 2 pilot study of Acthar Gel for chronic inflammatory demyelinating polyneuropathy has been withdrawn.